|
1
|
DiGiovanni CW, Patel A, Calfee R and
Nickisch F: Osteonecrosis in the foot. J Am Acad Orthop Surg.
15:208–217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lafforgue P: Pathophysiology and natural
history of avascular necrosis of bone. Joint Bone Spine.
73:500–507. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Powell C, Chang C and Gershwin ME: Current
concepts on the pathogenesis and natural history of steroid-induced
osteonecrosis. Clin Rev Allergy Immunol. 41:102–113. 2011.
View Article : Google Scholar
|
|
4
|
Chao YC, Wang SJ, Chu HC, Chang WK and
Hsieh TY: Investigation of alcohol metabolizing enzyme genes in
Chinese alcoholics with avascular necrosis of hip joint,
pancreatitis and cirrhosis of the liver. Alcohol. 38:431–436. 2003.
View Article : Google Scholar
|
|
5
|
Juéry P: Avascular necrosis after a
steroid injection. CMAJ. 176:814author reply 814. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baksi DP: Treatment of post-traumatic
avascular necrosis of the femoral head by multiple drilling and
muscle-pedicle bone grafting. Preliminary report. J Bone Joint Surg
Br. 65:268–273. 1983.PubMed/NCBI
|
|
7
|
Lee CK and Hansen HR: Post-traumatic
avascular necrosis of the humeral head in displaced proximal
humeral fractures. J Trauma. 21:788–791. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Laroche M: Intraosseous circulation from
physiology to disease. Joint Bone Spine. 69:262–269. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dannemann C, Grätz KW, Riener MO and
Zwahlen RA: Jaw osteonecrosis related to bisphosphonate therapy: A
severe secondary disorder. Bone. 40:828–834. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martí-Carvajal A, Dunlop R and
Agreda-Perez L: Treatment for avascular necrosis of bone in people
with sickle cell disease. Cochrane Database Syst Rev.
4:CD0043442004.PubMed/NCBI
|
|
11
|
Levasseur R: Mechanisms of osteonecrosis.
Joint Bone Spine. 75:639–642. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamamoto T, Hirano K, Tsutsui H, Sugioka Y
and Sueishi K: Corticosteroid enhances the experimental induction
of osteonecrosis in rabbits with Shwartzman reaction. Clin Orthop
Relat Res. (316): 235–243. 1995.PubMed/NCBI
|
|
13
|
Yamamoto T, Irisa T, Sugioka Y and Sueishi
K, Yamamoto T, Irisa T, Sugioka Y and Sueishi K: Effects of pulse
methylprednisolone on bone and marrow tissues:
Corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum.
40:2055–2064. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kabata T, Kubo T, Matsumoto T, Hirata T,
Fujioka M, Takahashi KA, Yagishita S, Kobayashi M and Tomita K:
Onset of steroid-induced osteonecrosis in rabbits and its
relationship to hyperlipaemia and increased free fatty acids.
Rheumatology. 44:1233–1237. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoneda T, Williams P, Rhine C, Boyce BF,
Dunstan C and Mundy GR: Suramin suppresses hypercalcemia and
osteoclastic bone resorption in nude mice bearing a human squamous
cancer. Cancer Res. 55:1989–1993. 1995.PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Hofbauer LC, Neubauer A and Heufelder AE:
Receptor activator of nuclear factor-kappa B ligand and
osteoprotegerin: Potential implications for the pathogenesis and
treatment of malignant bone diseases. Cancer. 92:460–470. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Blair JM, Zheng Y and Dunstan CR: RANK
ligand. Int J Biochem Cell Biol. 39:1077–1081. 2007. View Article : Google Scholar
|
|
19
|
Nakashima K, Zhou X, Kunkel G, Zhang Z,
Deng JM, Behringer RR and de Crombrugghe B: The novel zinc
finger-containing transcription factor osterix is required for
osteoblast differentiation and bone formation. Cell. 108:17–29.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD,
Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, et al:
Endocrine regulation of energy metabolism by the skeleton. Cell.
130:456–469. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zoch ML, Clemens TL and Riddle RC: New
insights into the biology of osteocalcin. Bone. 82:42–49. 2016.
View Article : Google Scholar
|
|
22
|
Galindo M, Pratap J, Young DW,
Hovhannisyan H, Im HJ, Choi JY, Lian JB, Stein JL, Stein GS and van
Wijnen AJ: The bone-specific expression of Runx2 oscillates during
the cell cycle to support a G1-related antiproliferative function
in osteoblasts. J Biol Chem. 280:20274–20285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lian JB and Stein GS: Runx2/Cbfa1: A
multifunctional regulator of bone formation. Curr Pharm Des.
9:2677–2685. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karsenty G: Role of Cbfa1 in osteoblast
differentiation and function. Semin Cell Dev Biol. 11:343–346.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ducy P, Zhang R, Geoffroy V, Ridall AL and
Karsenty G: Osf2/Cbfa1: A transcriptional activator of osteoblast
differentiation. Cell. 89:747–754. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Komori T, Yagi H, Nomura S, Yamaguchi A,
Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, et al:
Targeted disruption of Cbfa1 results in a complete lack of bone
formation owing to maturational arrest of osteoblasts. Cell.
89:755–764. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mackie EJ: Osteoblasts: Novel roles in
orchestration of skeletal architecture. Int J Biochem Cell Biol.
35:1301–1305. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Harada S and Rodan GA: Control of
osteoblast function and regulation of bone mass. Nature.
423:349–355. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tingart M, Beckmann J, Opolka A, Matsuura
M, Wiech O, Grifka J and Grässel S: Influence of factors regulating
bone formation and remodeling on bone quality in osteonecrosis of
the femoral head. Calcif Tissue Int. 82:300–308. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Weinstein RS, Jilka RL, Parfitt AM and
Manolagas SC: Inhibition of osteoblastogenesis and promotion of
apoptosis of osteoblasts and osteocytes by glucocorticoids.
Potential mechanisms of their deleterious effects on bone. J Clin
Invest. 102:274–282. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wyles CC, Houdek MT, Crespo-Diaz RJ,
Norambuena GA, Stalboerger PG, Terzic A, Behfar A and Sierra RJ:
Adipose-derived mesenchymal stem cells are phenotypically superior
for regeneration in the setting of osteonecrosis of the femoral
head. Clin Orthop Relat Res. 473(10): 3080–3090. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gao YS and Zhang CQ: Comment on:
Osteogenic abilities of bone marrow stromal cells are not defective
in patients with osteonecrosis. Int Orthop. 34:457author reply 459.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Teitelbaum SL: Bone resorption by
osteoclasts. Science. 289:1504–1508. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Theoleyre S, Wittrant Y, Tat SK, Fortun Y,
Redini F and Heymann D: The molecular triad OPG/RANK/RANKL:
Involvement in the orchestration of pathophysiological bone
remodeling. Cytokine Growth Factor Rev. 15:457–475. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yamada Y, Ando F, Niino N and Shimokata H:
Association of polymorphisms of the osteoprotegerin gene with bone
mineral density in Japanese women but not men. Mol Genet Metab.
80:344–349. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gori F, Hofbauer LC, Dunstan CR, Spelsberg
TC, Khosla S and Riggs BL: The expression of osteoprotegerin and
RANK ligand and the support of osteoclast formation by
stromal-osteoblast lineage cells is developmentally regulated.
Endocrinology. 141:4768–4776. 2000.PubMed/NCBI
|
|
37
|
Grässel S, Beckmann J, Rath B, Vogel M,
Grifka J and Tingart M: Expression profile of matrix
metalloproteinase-2 and -9 and their endogenous tissue inhibitors
in osteonecrotic femoral heads. Int J Mol Med. 26:127–133. 2010.
View Article : Google Scholar : PubMed/NCBI
|
